MBX Biosciences (NASDAQ:MBX) executives outlined key clinical and development milestones expected through 2026 during an Oppenheimer life sciences team event featuring CEO Kent Hawryluk and Chief ...
BioNTech and partner DualityBio are accelerating the development of their B7-H3 antibody-drug conjugate into a phase 3 trial for metastatic castration-resistant prostate cancer (mCRPC). | BioNTech and ...
Shares of uniQure plummeted more than 40% in premarket trading Monday after the company confirmed the FDA has rejected its current data package for AMT-130, a highly anticipated gene therapy for ...
Despite all the on and off-field chaos, Crystal Palace, 13th in the Premier League but 10 points above the relegation zone, ...
First-ever randomized, placebo-controlled Phase 1 trial - published in The Lancet Microbe - supports SNIPR001’s safety, tolerability, and restriction to the gastrointestinal tract in healthy ...
A few months into GLP-1 treatment, many patients encounter an unexpected and distressing side effect: significant hair loss.
Phase One of the historic site’s Visitors Center expansion is officially complete, marking the first major renovation of the ...
Audits, RCMP investigation, lawsuits and now an inquiry have yielded enough pertinent information to fill several large textbooks about the Winnipeg's police HQ. Nonetheless, there remain questions ...
This important study demonstrates that a peri-nuclear actomyosin network, present in some types of human cells, facilitates kinetochore-spindle attachment of chromosomes in unfavorable locations - ...
Xeris Biopharma benefits from the FDA's CRL to Corcept's relacorilant, removing a major competitive threat to Recorlev sales ...
When WSDOT closed two lanes of the northbound 1st Avenue South Bridge after an inspection revealed problems 2+ weeks ago, an update was promised by this Friday. Today, we have it - a repair plan ...
Real Madrid and Manchester City will once again renew Champions League acquaintances after being paired together in the Round of 16.